178552-82-4

Upstream product

• 5292-43-3 bromoacetic acid tert-butyl ester 
• 1738-68-7 Gly-OBz 
• 146432-43-1 N-(2-bromoethyl)-N-[2-(1,1-dimethylethoxy)-2-oxoethyl]glycine 1,1-dimethylethyl ester 
• 1738-76-7 glycine benzyl ester p-toluenesulfonic acid salt 
• 146432-41-9 [tert-Butoxycarbonylmethyl-(2-hydroxy-ethyl)-amino]-acetic acid tert-butyl ester 

Downstream Products

• 1362022-16-9 C₅₂H₇₆N₄O₁₁ 
• 1243304-20-2 C₂₂H₃₂N₄O₁₁ 
• 1362022-22-7 C₃₈H₆₄N₄O₁₁ 
• 174267-71-1 3,9-Bis(tert-butoxycarbonylmethyl)-6-carboxymethyl-3,6,9-triazaundecanedioic acid-di-tert-butyl ester 
• 1163255-14-8 4-benzyloxycarbonylmethyl-1,1,7,7-tetra(carboxymethyl)-1,4,7-triazaheptane 
• 1532551-36-2 C₄₆H₆₉N₅O₁₃ 
• 1532551-37-3 C₃₀H₃₇N₅O₁₃ 
• 1566605-91-1 1-methoxycarbonylmethyl-1-(4-nitrobenzenesulfonyl)-4,4-bis(tert-butoxycarbonylmethyl)-1,4-diazabutane 
• 1566605-75-1 C₅₁H₈₉N₇O₁₈ 
• 1566605-79-5 C₄₄H₆₇N₅O₁₄ 
• 1566605-85-3 C₆₂H₉₅N₇O₁₇ 
• 1566605-86-4 C₄₇H₈₁N₇O₁₇ 
• 1566605-87-5 C₄₈H₈₃N₇O₁₇ 
• 1566605-88-6 C₆₆H₁₁₁N₉O₂₁ 

Relevant academic research and scientific papers

Controlling multivalency and multimodality: Up to pentamodal dendritic platforms based on diethylenetriaminepentaacetic acid cores

A highly versatile synthetic strategy is described to generate multimodal and multivalent platforms based on a diethylenetriaminepentaacetic (DTPA) core. Compounds with different functionalization patterns, from mono- to pentamodal, have been prepared using robust and simple chemistry.

Biocompatible, multifunctional, and well-defined OEG-based dendritic platforms for biomedical applications

Given the growing importance of drug and gene delivery systems, imaging agents, biosensors, and theranostics, there is a need to develop new multifunctional and biocompatible platforms. Here we synthesized and fully characterized a family of novel multifu

A self-assembled complex with a Titanium(IV) catecholate core as a potential bimodal contrast agent

A ditopic chelating ligand (H64) that bears catechol and diethylenetriamine-N,N,N',N',N'-pentaacetate (DTPA) has been designed and shown to specifically bind lanthanide(III) ions at the DTPA core ([Ln(H 24)(H2O)]-/su

Cascade polymer complexes, process for their production and pharamceutical agents containing said complexes

Cascade polymer complexes that contain a) complexing ligands of general formula I in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand for a direct bond or a cascade reproduction

Substituted DTPA monoamides of the central carboxylic acid group and their metal complexes

Diethylenetriaminepentaacetic acid monoamide derivatives, their complexes and complex salts, containing an element of atomic numbers 21-29, 31, 32, 39, 42-44, 49 or 57-83, pharmaceutical agents containing these compounds, their use as contrast media and process for their production.

Process for the production of DTPA-monoamides of the central carboxylic acid and their use as pharmaceutical agents

A process for the production of of general formula I diethylenetriaminepentacarboxylic acid monoamide derivatives STR1 in which E1, E2 and Z have varying meanings.

Process for the production of DTPA-tetraesters of terminal carboxylic acids

The invention relates to a process for the production of diethylenetriaminepentacarboxylic acid tetraesters of general formula I STR1 in which R1 and Z have different meanings.